English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 29, 2026

NYU Langone study shows how leukemia cells invade lungs and impact breathing
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Study finds link between cardiovascular risk factors and visual impairment in Latinos
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

FDA approves Viridian's Lumvoa for thyroid eye disease treatment
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Researchers review the complex relationship between cellular senescence and stemness in disease
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Four ovarian cancer drug candidates advance amid recent FDA approvals
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Study finds difficult childbirth is not unique to humans, challenges long-held theory
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Zymeworks to acquire Theravance for $929 million, adds lung drug and royalty deals
+ Pharmaceuticals
Patient Daily | Jun 29, 2026

Researchers identify immune pathway linking smoking to cardiovascular disease risk

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation